CFLAR and neoplasm: Some promising splice isoform targets have also been reported, including VEGF165b, c-FLIPL, CCND1b, etc. Thus, this article will review the tumor-associated splicing variants arising from AS, aiming to offer an insight into CRC-targeted splicing therapy.